SEARCH

SEARCH BY CITATION

References

  • Bergsagel, P.L., Kuehl, W.M., Zhan, F., Sawyer, J., Barlogie, B. & Shaughnessy, J. (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood, 106, 296303.
  • Ely, S., Di Liberto, M., Niesvizky, R., Baughn, L.B., Cho, H.J., Hatada, E.N., Knowles, D.M., Lane, J. & Chen-Kiang, S. (2005) Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Research, 65, 1134511353.
  • Kapoor, P., Greipp, P.T., Morice, W.G., Rajkumar, S.V., Witzig, T.E. & Greipp, P.R. (2008) Anti-CD20 monoclonal antibody therapy in multiple myeloma. British Journal of Haematology, 141, 135148.
  • Mateo, G., Castellanos, M., Rasillo, A., Gutiérrez, N.C., Montalbán, M.A., Martín, M.L., Hernández, J.M., López-Berges, M.C., Montejano, L., Bladé, J., Mateos, M.V., Sureda, A., De la Rubia, J., Díaz-Mediavilla, J., Pandiella, A., Lahuerta, J.J., Orfao, A. & San Miguel, J.F. (2005) Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clinical Cancer Research, 15, 36613667.
  • Matsui, W., Wang, Q., Barber, J.P., Brennan, S., Smith, B.D., Borrello, I., McNiece, I., Lin, L., Ambinder, R.F., Peacock, C., Watkins, D.N., Huff, C.A. & Jones, R.J. (2008) Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Research, 68, 190197.
  • Moreau, P., Facon, T., Leleu, X., Morineau, N., Huyghe, P., Harousseau, J.L., Bataille, R. & Avet-Loiseau, H. (2002) Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood, 100, 15791583.
  • Robillard, N., Avet-Loiseau, H., Garand, R., Moreau, P., Pineau, D., Rapp, M.J., Harousseau, J.L. & Bataille, R. (2003) CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood, 102, 10701071.
  • Sahara, N., Takeshita, A., Shigeno, K., Fujisawa, S., Takeshita, K., Naito, K., Ihara, M., Ono, T., Tamashima, S., Nara, K., Ohnishi, K. & Ohno, R. (2002) Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma. British Journal of Haematology, 117, 882885.
  • San Miguel, J.F., González, M., Gascón, A., Moro, M.J., Hernández, J.M., Ortega, F., Jimenez, R., Guerras, L., Romero, M. & Casanova, F. (1991) Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies. British Journal of Haematology, 1991, 77.
  • Zhan, F., Huang, Y., Colla, S., Stewart, J.P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., Anaissie, E., Hollmig, K., Pineda-Roman, M., Tricot, G., Van Rhee, F., Walker, R., Zangari, M., Crowley, J., Barlogie, B. & Shaughnessy, J.D. Jr. (2006) The molecular classification of myeloma. Blood, 108, 20202028.